These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1728991)
1. The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues. Frank MM; Basta M; Fries LF Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S82-6. PubMed ID: 1728991 [TBL] [Abstract][Full Text] [Related]
2. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. Theofilopoulos AN; Dixon FJ; Bokisch VA J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225 [TBL] [Abstract][Full Text] [Related]
3. The covalent interaction of C3 with IgG immune complexes. Vivanco F; Muñoz E; Vidarte L; Pastor C Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338 [TBL] [Abstract][Full Text] [Related]
4. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes. Muñoz E; Vidarte L; Pastor C; Casado M; Vivanco F Eur J Immunol; 1998 Aug; 28(8):2591-7. PubMed ID: 9710236 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes. Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918 [TBL] [Abstract][Full Text] [Related]
6. 7th International Immunoglobulin Conference: Mechanisms of action. Basta M; Branch DR Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):87-8. PubMed ID: 25546774 [TBL] [Abstract][Full Text] [Related]
7. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis. Scribner DJ; Fahrney D J Immunol; 1976 Apr; 116(4):892-7. PubMed ID: 1254970 [TBL] [Abstract][Full Text] [Related]
9. In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations. Spycher M; Matozan K; Minnig K; Zehnder R; Miescher S; Hoefferer L; Rieben R Vox Sang; 2009 Nov; 97(4):348-54. PubMed ID: 19656348 [TBL] [Abstract][Full Text] [Related]
11. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum. Gadd KJ; Reid KB Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962 [TBL] [Abstract][Full Text] [Related]
12. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates. Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). Arnaout MA; Todd RF; Dana N; Melamed J; Schlossman SF; Colten HR J Clin Invest; 1983 Jul; 72(1):171-9. PubMed ID: 6874946 [TBL] [Abstract][Full Text] [Related]
15. Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes. Shoham-Kessary H; Naot Y; Gershon H Clin Exp Immunol; 1998 Jul; 113(1):77-84. PubMed ID: 9697987 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G. Griffin FM; Bianco C; Silverstein SC J Exp Med; 1975 Jun; 141(6):1269-77. PubMed ID: 1092796 [TBL] [Abstract][Full Text] [Related]